Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737293 · ClinicalTrials.gov registry record · NA
Whole Egg Intake and the Mediterranean Diet
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02737293: Clinical Trial NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT02737293 is a NA study that was terminated before completion, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02737293, a NA study, was terminated before completion, sponsored by USDA Grand Forks Human Nutrition Research Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This project will evaluate the daily intake of whole eggs in the Mediterranean Diet (Med Diet). Cholesterol levels are normally related to cardiovascular disease (CVD) risk. Dietary fat and the total diet makeup are well known modifiers of CVD risk. The Med Diet has been shown to decrease blood lipids (fats) and reduce inflammation. Cholesterol intake from eggs may not be as bad as once thought and, in fact, may help to improve the blood lipid (fat) levels. This study is being done to test how the addition of eggs to a Med Diet affects blood lipids and other risk markers for CVD.
Primary Outcome
Assess lipid metabolism response to the intervention.
Interventions
- OTHER Control Diet
- OTHER Med Diet
- OTHER Med Diet + Whole Egg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
Why NCT02737293 stopped before completion
NCT02737293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Control Diet is the first listed.
NCT02737293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02737293 about?
NCT02737293 is a clinical study titled "Whole Egg Intake and the Mediterranean Diet". This project will evaluate the daily intake of whole eggs in the Mediterranean Diet (Med Diet). Cholesterol levels are normally related to cardiovascular disease (CVD) risk. Dietary fat and the total diet makeup are well known modifiers of CVD risk. The Med Diet has been shown to decrease blood lipi...
What is the current status of trial NCT02737293?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2016-04. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT02737293?
The interventions under investigation include: Control Diet (OTHER), Med Diet (OTHER), Med Diet + Whole Egg (OTHER).
Who is sponsoring clinical trial NCT02737293?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02737293's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia